Sponsored

  • Asia-Pacific In Vitro Diagnostics Market on Track to Reach $36.02 Billion by 2031
    ‘Asia-Pacific In Vitro Diagnostics Market by Offering (Kits, Software), Technology (Immunoassay, Molecular Diagnostics [PCR, NGS, Microarray], Rapid Tests, Biochemistry), Application (Infectious Diseases, Oncology), Diagnostic Approach - Forecast to 2031.’
    Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5750

    Key Players
    The key players operating in the Asia-Pacific IVD market are Abbott Laboratories (U.S.), Becton, Dickinson and Company (U.S.), Sysmex Corporation (Japan), bioMérieux SA (France), Bio-Rad Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Seegene Inc. (South Korea), Illumina, Inc. (U.S.), Shenzhen Mindray Bio-Medical Electronics Co., Ltd (China), Siemens Healthineers AG (Germany), Thermo Fisher Scientific Inc. (U.S.), QuidelOrtho Corporation (U.S.), and Agilent Technologies Inc. (U.S.).
    Asia-Pacific IVD Market: Future Outlook
    The Asia-Pacific IVD market is segmented by Offering (Kits & Reagents, Instruments, and Software & Services), Technology (Immunoassay/Immunochemistry, Biochemistry/Clinical Chemistry, Molecular Diagnostics, Point of Care (POC) Diagnostics, Whole Blood Glucose Monitoring, Microbiology, Hematology, Coagulation/Hemostasis, Urinalysis, and Other Technologies), Application (Infectious Diseases, Oncology, Diabetes, Cardiology, Nephrology, Autoimmune Disorders, and Other Applications), Diagnostic Approach (Lab Testing, OTC/Self-testing, and Point of Care Testing), and End User (Diagnostic Laboratories, Hospitals & Clinics, Home Healthcare, and Other End Users), and Countries. The study also evaluates industry competitors and analyzes their market share at the country level.
    𝐇𝐚𝐯𝐞 𝐚𝐧𝐲 𝐪𝐮𝐞𝐫𝐲 𝐀𝐒𝐊 𝐄𝐗𝐏𝐄𝐑𝐓 :
    https://www.meticulousresearch.com/speak-to-analyst/cp_id=5750
    by Offering
    • Kits & Reagents
    • Instruments
    • Software & Services
    by Technology
    • Molecular Diagnostics
    o Polymerase Chain Reaction (PCR)
    o Hybridization
    o Isothermal Nucleic Acid Amplification Technology
    o DNA Sequencing & Next-generation Sequencing
    o Microarrays
    o Mass Spectrometry
    o Other Molecular Diagnostic Technologies
    • Point of Care (PoC) Diagnostics
    o Lateral Flow Assays/Rapid Tests
    o POC Molecular Diagnostics
    o Other PoC Products
    • Immunoassay/Immunochemistry
    o Enzyme-linked Immunosorbent Assays (ELISA)
    o Radioimmunoassays
    o Western Blotting
    o Enzyme-Linked Immunospot Assays
    o Immunohistochemistry (IHC)
    • Biochemistry/Clinical Chemistry
    o Metabolic Panel
    o Electrolyte Panel
    o Liver Panel
    o Lipid Profile
    o Renal Profile
    o Thyroid Function Panel
    • Whole Blood Glucose Monitoring
    • Microbiology
    • Hematology
    • Coagulation/Hemostasis
    • Urinalysis
    • Other IVD Technologies
    by Application
    • Infectious Diseases
    o COVID-19 Testing
    o ******** Transmitted Diseases (STD) Testing
    o Healthcare-associated Infections (HAIs)
    o Hepatitis
    o HIV
    o Tropical Diseases
    o Respiratory Infections (Excluding Influenza)
    o Influenza
    o Other Infectious Diseases
    • Oncology
    • Diabetes
    • Cardiology
    • Nephrology
    • Autoimmune Disorders
    • Other Applications
    by Diagnostic Approach
    • Lab Testing
    • OTC/Self-testing
    • Point of Care Testing
    by End User
    • Diagnostic Laboratories
    • Hospitals & Clinics
    • Home Healthcare
    • Other End Users
    by Country/Region
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Thailand
    • Singapore
    • Indonesia
    • Rest of Asia-Pacific
    Browse Here:
    https://www.meticulousresearch.com/product/asia-pacific-in-vitro-diagnostics-market-5750
    Geographic Review
    Key questions answered in the report:
    • Which are the high-growth market segments in terms of offering, technology, application, diagnostic approach, end user, and country?
    • What was the historical market for IVD testing in Asia-Pacific?
    • What are the market forecasts and estimates for the period 2024–2031?
    • What are the major drivers, restraints, challenges, and opportunities in the Asia-Pacific IVD market?
    • Who are the major players in the Asia-Pacific IVD market?
    Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5750

    ContactUs:
    MeticulousResearch®
    Email- [email protected]
    ContactSales-+1-646-781-8004
    Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research

    Asia-Pacific In Vitro Diagnostics Market on Track to Reach $36.02 Billion by 2031 ‘Asia-Pacific In Vitro Diagnostics Market by Offering (Kits, Software), Technology (Immunoassay, Molecular Diagnostics [PCR, NGS, Microarray], Rapid Tests, Biochemistry), Application (Infectious Diseases, Oncology), Diagnostic Approach - Forecast to 2031.’ Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5750 Key Players The key players operating in the Asia-Pacific IVD market are Abbott Laboratories (U.S.), Becton, Dickinson and Company (U.S.), Sysmex Corporation (Japan), bioMérieux SA (France), Bio-Rad Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Seegene Inc. (South Korea), Illumina, Inc. (U.S.), Shenzhen Mindray Bio-Medical Electronics Co., Ltd (China), Siemens Healthineers AG (Germany), Thermo Fisher Scientific Inc. (U.S.), QuidelOrtho Corporation (U.S.), and Agilent Technologies Inc. (U.S.). Asia-Pacific IVD Market: Future Outlook The Asia-Pacific IVD market is segmented by Offering (Kits & Reagents, Instruments, and Software & Services), Technology (Immunoassay/Immunochemistry, Biochemistry/Clinical Chemistry, Molecular Diagnostics, Point of Care (POC) Diagnostics, Whole Blood Glucose Monitoring, Microbiology, Hematology, Coagulation/Hemostasis, Urinalysis, and Other Technologies), Application (Infectious Diseases, Oncology, Diabetes, Cardiology, Nephrology, Autoimmune Disorders, and Other Applications), Diagnostic Approach (Lab Testing, OTC/Self-testing, and Point of Care Testing), and End User (Diagnostic Laboratories, Hospitals & Clinics, Home Healthcare, and Other End Users), and Countries. The study also evaluates industry competitors and analyzes their market share at the country level. 𝐇𝐚𝐯𝐞 𝐚𝐧𝐲 𝐪𝐮𝐞𝐫𝐲 𝐀𝐒𝐊 𝐄𝐗𝐏𝐄𝐑𝐓 : https://www.meticulousresearch.com/speak-to-analyst/cp_id=5750 by Offering • Kits & Reagents • Instruments • Software & Services by Technology • Molecular Diagnostics o Polymerase Chain Reaction (PCR) o Hybridization o Isothermal Nucleic Acid Amplification Technology o DNA Sequencing & Next-generation Sequencing o Microarrays o Mass Spectrometry o Other Molecular Diagnostic Technologies • Point of Care (PoC) Diagnostics o Lateral Flow Assays/Rapid Tests o POC Molecular Diagnostics o Other PoC Products • Immunoassay/Immunochemistry o Enzyme-linked Immunosorbent Assays (ELISA) o Radioimmunoassays o Western Blotting o Enzyme-Linked Immunospot Assays o Immunohistochemistry (IHC) • Biochemistry/Clinical Chemistry o Metabolic Panel o Electrolyte Panel o Liver Panel o Lipid Profile o Renal Profile o Thyroid Function Panel • Whole Blood Glucose Monitoring • Microbiology • Hematology • Coagulation/Hemostasis • Urinalysis • Other IVD Technologies by Application • Infectious Diseases o COVID-19 Testing o Sexually Transmitted Diseases (STD) Testing o Healthcare-associated Infections (HAIs) o Hepatitis o HIV o Tropical Diseases o Respiratory Infections (Excluding Influenza) o Influenza o Other Infectious Diseases • Oncology • Diabetes • Cardiology • Nephrology • Autoimmune Disorders • Other Applications by Diagnostic Approach • Lab Testing • OTC/Self-testing • Point of Care Testing by End User • Diagnostic Laboratories • Hospitals & Clinics • Home Healthcare • Other End Users by Country/Region • China • Japan • India • Australia • South Korea • Thailand • Singapore • Indonesia • Rest of Asia-Pacific Browse Here: https://www.meticulousresearch.com/product/asia-pacific-in-vitro-diagnostics-market-5750 Geographic Review Key questions answered in the report: • Which are the high-growth market segments in terms of offering, technology, application, diagnostic approach, end user, and country? • What was the historical market for IVD testing in Asia-Pacific? • What are the market forecasts and estimates for the period 2024–2031? • What are the major drivers, restraints, challenges, and opportunities in the Asia-Pacific IVD market? • Who are the major players in the Asia-Pacific IVD market? Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5750 ContactUs: MeticulousResearch® Email- [email protected] ContactSales-+1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
    0 Comments 0 Shares
  • Meticulous Research®—a leading global market research company, published a research report titled, ‘Sequencing Kits Market by Type (Nucleic Acid Extraction & Amplification, Library Preparation, Control) Technology (NGS, Sanger) Application (Drug Discovery, Oncology, Reproductive Health, Infectious Diseases) End User - Global Forecast to 2030.’

    According to this latest publication from Meticulous Research®, the sequencing kits market along with sequencing reagents is projected to reach $21.9 billion by 2030, at a CAGR of 15.3% during the forecast period. The growth of the sequencing kits market is driven by the increasing prevalence of cancer & genetic disorders, rising healthcare expenditures, increasing funding for research activities, the surge in genome mapping programs, the decreasing costs of sequencing procedures, the growing need for the early detection & prevention of diseases, technological advancements in sequencing products, the improving regulatory and reimbursement scenarios for NGS-based diagnostic tests, and government initiatives promoting the use of sequencing in clinical & research applications. However, the high costs of sequencing kits & reagents and the ethical & legal issues related to DNA sequencing-based diagnosis are factors restraining the growth of this market.

    Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5656

    Additionally, developing portable sequencing technologies and increasing partnerships & collaborations among NGS product manufacturers to expand and improve product offerings are prominent trends in the sequencing kits market.

    Sequencing Kits & Reagents Market: Future Outlook

    The sequencing kits market along with sequencing reagents is segmented based on type [control kits & reagents, library preparation kits & reagents, nucleic acid extraction & amplification kits & reagents, sequencing kits & reagents, other kits & reagents], technology [next-generation sequencing, sanger sequencing, third & fourth-generation sequencing, other sequencing technologies] application [research applications (drug discovery, agricultural & animal research, other research applications), clinical applications (reproductive health, oncology, infectious diseases, other clinical applications)], end user [pharmaceutical & biotechnology companies, hospitals & diagnostic laboratories, academic & research institutes, other end users], and Geography. The study also evaluates industry competitors and analyzes the market at the regional and country levels.

    Speak To Analyst: https://www.meticulousresearch.com/speak-to-analyst/cp_id=5656


    Quick Buy: https://www.meticulousresearch.com/Checkout/23122617

    Geographic Review

    This research report analyzes major geographies and provides a comprehensive analysis of North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, Rest of Latin America) and the Middle East & Africa.


    Key Players

    The key players operating in the sequencing kits market along with sequencing reagents are Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), PerkinElmer, Inc. (U.S.), QIAGEN N.V. (Netherlands), Agilent Technologies, Inc. (U.S.), Pacific Biosciences of California, Inc. (U.S.), Danaher Corporation (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Oxford Nanopore Technologies Plc. (U.K.), 10X Genomics, Inc. (U.S.), and Beijing Genomics Institute (BGI) (China).

    Key questions answered in the report:

    Which are the high-growth market segments in terms of type, technology, application, end user, and region/country?
    What was the historical market size for sequencing kits market globally?
    What are the market forecasts and estimates for the period 2023–2030?
    What are the major drivers, restraints, challenges, and opportunities in the global sequencing kits market?
    Who are the major players in the global sequencing kits market?
    How is the competitive landscape, and who are the market leaders in the global sequencing kits market?
    What are the recent developments in the sequencing kits market?
    What strategies are adopted by the major players in the sequencing kits market?
    What are the geographical trends and high-growth regions/countries?
    Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5656
    Contact Us:
    Meticulous Research®
    Email- [email protected]
    Contact Sales- +1-646-781-8004
    Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research


    Meticulous Research®—a leading global market research company, published a research report titled, ‘Sequencing Kits Market by Type (Nucleic Acid Extraction & Amplification, Library Preparation, Control) Technology (NGS, Sanger) Application (Drug Discovery, Oncology, Reproductive Health, Infectious Diseases) End User - Global Forecast to 2030.’ According to this latest publication from Meticulous Research®, the sequencing kits market along with sequencing reagents is projected to reach $21.9 billion by 2030, at a CAGR of 15.3% during the forecast period. The growth of the sequencing kits market is driven by the increasing prevalence of cancer & genetic disorders, rising healthcare expenditures, increasing funding for research activities, the surge in genome mapping programs, the decreasing costs of sequencing procedures, the growing need for the early detection & prevention of diseases, technological advancements in sequencing products, the improving regulatory and reimbursement scenarios for NGS-based diagnostic tests, and government initiatives promoting the use of sequencing in clinical & research applications. However, the high costs of sequencing kits & reagents and the ethical & legal issues related to DNA sequencing-based diagnosis are factors restraining the growth of this market. Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5656 Additionally, developing portable sequencing technologies and increasing partnerships & collaborations among NGS product manufacturers to expand and improve product offerings are prominent trends in the sequencing kits market. Sequencing Kits & Reagents Market: Future Outlook The sequencing kits market along with sequencing reagents is segmented based on type [control kits & reagents, library preparation kits & reagents, nucleic acid extraction & amplification kits & reagents, sequencing kits & reagents, other kits & reagents], technology [next-generation sequencing, sanger sequencing, third & fourth-generation sequencing, other sequencing technologies] application [research applications (drug discovery, agricultural & animal research, other research applications), clinical applications (reproductive health, oncology, infectious diseases, other clinical applications)], end user [pharmaceutical & biotechnology companies, hospitals & diagnostic laboratories, academic & research institutes, other end users], and Geography. The study also evaluates industry competitors and analyzes the market at the regional and country levels. Speak To Analyst: https://www.meticulousresearch.com/speak-to-analyst/cp_id=5656 Quick Buy: https://www.meticulousresearch.com/Checkout/23122617 Geographic Review This research report analyzes major geographies and provides a comprehensive analysis of North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, Rest of Latin America) and the Middle East & Africa. Key Players The key players operating in the sequencing kits market along with sequencing reagents are Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), PerkinElmer, Inc. (U.S.), QIAGEN N.V. (Netherlands), Agilent Technologies, Inc. (U.S.), Pacific Biosciences of California, Inc. (U.S.), Danaher Corporation (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Oxford Nanopore Technologies Plc. (U.K.), 10X Genomics, Inc. (U.S.), and Beijing Genomics Institute (BGI) (China). Key questions answered in the report: Which are the high-growth market segments in terms of type, technology, application, end user, and region/country? What was the historical market size for sequencing kits market globally? What are the market forecasts and estimates for the period 2023–2030? What are the major drivers, restraints, challenges, and opportunities in the global sequencing kits market? Who are the major players in the global sequencing kits market? How is the competitive landscape, and who are the market leaders in the global sequencing kits market? What are the recent developments in the sequencing kits market? What strategies are adopted by the major players in the sequencing kits market? What are the geographical trends and high-growth regions/countries? Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5656 Contact Us: Meticulous Research® Email- [email protected] Contact Sales- +1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
    0 Comments 0 Shares
Sponsored

Sponsored

Don't forget, ads time: PentaVerge | AQU | Debwan | ICICTE | Nasseej | ESol | OUST | CorpSNet | PoemsBook | TopDeals | TheReaderView